Skip to content
Discover expert tips and trusted advice on maintaining heal…

Zimbabwe Turns Down ‘Lopsided’ American Health Aid Agreement Due to Information Fears

Health aid illustration
The proposed American funding would have supported programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years because of the United States' insistence on confidential information.

This move was revealed following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "skewed".

A government representative has since clarified that the US was requesting genetic material for scientific study and commercial purposes but was unwilling to share the resulting advantages from future medical innovations.

"We will now turn to the challenging and unfortunate task of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for more dialogue to find a deal suitable to both sides so the nation's critical HIV treatment initiative can continue.

Wider Implications

This rejection comes after a comparable situation in neighbouring Kenya, where a court halted a related health funding agreement after concerns were raised about the security of citizens' health data.

Since resuming office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

USAID had managed assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government agreements to enhance openness and accountability.

As per reports, 16 nations in Africa have so far signed similar agreements, constituting over $18.3bn in new funding.

Specifics of the Declined Deal

The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this cooperation could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through American-funded programmes," Tremont added.

However, government spokesperson Nick Mangwana said the arrangement was "unequal".

"Our nation was requested to provide its biological resources and data for a long time, without any corresponding guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," his statement read.

"In essence, our country would provide the raw materials for medical research with no certainty that the end products would be accessible to our citizens should a future disease outbreak emerge."

National Interest and Global Health

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems already established through the global health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with potential global health emergencies.

"This mechanism is designed to ensure that when a country provides its data, the benefits – including vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to develop them."

The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We encourage continued discussions with our US partners on how subsequent collaboration might be designed in a manner that honours the sovereignty and interests of both nations."

Health Experts Response

A leading public health body said it acknowledged the government's concerns, but recommended that negotiations must proceed considering much of the nation's HIV programmes depended on international support.

"If specific concerns exist, such as those relating to information security or agreement terms, these can often be resolved via technical clarification and negotiated safeguards," it added.

This impasse emphasises the ongoing challenges between accepting much-needed foreign assistance and safeguarding a country's data in an increasingly data-driven world.

About the author

Jacob Saunders

Optometrist and vision care advocate with 10 years of experience in clinical eye health.

ClearVisionHub

Type to search articles.